MedPath

Intrathecal Dexmedetomidine vs Midazolame

Phase 4
Completed
Conditions
Postoperative Pain
Interventions
Registration Number
NCT06315634
Lead Sponsor
National Cancer Institute, Egypt
Brief Summary

Prospective Randomized Controlled Clinical Trial to Compare Intrathecal Dexmedetomidine Versus Midazolame in Orthopedic Cancer Surgeries

Detailed Description

Comparison of intrathecal dexmedetomidine plus Bupivacaine vs intrathecal midazolam plus Bupivacaine on duration of sensory and motor blockade and hemodynamic parameters of patients

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
75
Inclusion Criteria
  • Patients undergoing lower limb orthopedic cancer surgery.
  • ASA I, II, III.
  • Age 20 to 70 year
  • Healthy volunteers
Exclusion Criteria
  • Age less than 20 and older than 70.
  • ASA IV, V.
  • patients' refusal.
  • patients with coagulopathy.
  • patients with severe valvular stenosis
  • patients with infection at site of injection

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Heavy Bupivacaine plus dexmedetomidineDexmedetomidine2.5 ml of 0.5% hyperbaric Bupivacaine plus 5 micrograms dexmedetomidine in 0.5 ml 0.9 % saline
Heavy Bupivacaine plus midazolamMidazolam2.5 ml of 0.5% hyperbaric Bupivacaine plus 2 milligrams midazolam in 0.5 ml 0.9 % saline
Heavy Bupivacaine plus normal salineBupivacain2.5 ml of 0.5% hyperbaric Bupivacaine plus 0.5 ml 0.9 % saline
Heavy Bupivacaine plus dexmedetomidineBupivacain2.5 ml of 0.5% hyperbaric Bupivacaine plus 5 micrograms dexmedetomidine in 0.5 ml 0.9 % saline
Heavy Bupivacaine plus midazolamBupivacain2.5 ml of 0.5% hyperbaric Bupivacaine plus 2 milligrams midazolam in 0.5 ml 0.9 % saline
Primary Outcome Measures
NameTimeMethod
Duration of sensory block12 hours

Duration of sensory block after spinal anesthesia by the ability of the patient to demonstrate the pinprick sensation

Secondary Outcome Measures
NameTimeMethod
Incidence of vomiting occurrence12 hours

The patient will be reported in case of vomiting occurrence

Sedation12 hours

Ramsay's sedation score1: anxious, agitated and restlessness, 2: oriented and cooperative, 3: responds to command only, 4: brisk response to loud voice and light glabellar tap, 5: sluggish to no response to light glabellar tap or loud auditory stimulus, 6: no response even to pain

Change in mean arterial blood pressure12 hours

Non invasive blood pressure measurement

Duration of motor block12 hours

Ability of patient to regain full motor power

Change in heart rate12 hours

Heart rate will be compared between the three groups and will be compared with baseline preoperative values in each group

Trial Locations

Locations (1)

National cancer institute

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath